Butterfly Network (BFLY) Long-Term Investments (2020)

Butterfly Network (BFLY) posted Long-Term Investments of $414.3 million for Q4 2020, little changed sequentially from $414.2 million in Q3 2020.

Butterfly Network (BFLY) Long-Term Investments (2020) Analysis & Trends

Butterfly Network has reported Long-Term Investments for 1 years, with the latest figure at $414.3 million in Q4 2020.

Quarterly Long-Term Investments changed N/A year-over-year to $414.3 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $414.3 million (changed N/A YoY) and the FY2020 annual result came in at $414.3 million, changed N/A from the prior year.
Long-Term Investments was little changed at $414.3 million in Q4 2020 per BFLY's latest filing, from $414.2 million in the prior quarter.
Over five years, Long-Term Investments peaked at $414.3 million in Q4 2020 and troughed at $414.1 million in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	1.11 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	-
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	-
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	2.25 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	244.10 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	-
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	175.52 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	-
10	Butterfly Network	2.41 Bn	2.28 Bn	23.29 Mn	-

Download Data